Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
125
days
4H‐CRCXL Mitigates RasV12‐Induced Phenotypes in Glioblastoma Model of Drosophila
AuthorsPradeep Kumar; Vaishali Raghuvanshi; Prabhat Kumar; Rohit Kumar; Brijesh Singh Chauhan; Diksha Katiyar; Saripella Srikrishna
Affiliations1. Cancer and Neurobiology Laboratory, Department of Biochemistry, Institute of Science Banaras Hindu University Varanasi Uttar Pradesh India; 2. Department of Chemistry MMV, Banaras Hindu University Varanasi Uttar Pradesh India
350
days
Integrated Immunological Analysis of Interactions Between CXCL13+ T Cells and LAMP3+ DC in the Immunotherapy Response of Bladder Cancer
AuthorsLin Zhou; Jinchao Zhu; Yushan Liu; Bin Xu
Affiliations1. Department of Urology Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China; 2. Department of Pathology Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China
89
days
Epitranscriptomic Regulation of ALDOA by SHMT2‐Mediated m6A Modification Drives Gastric Cancer Malignancy
AuthorsPeng Li; Chengyun Niu; Dongni Zhao; Changmiao Wang
Affiliations1. Department of General Surgery The First Affiliated Hospital of Dalian Medical University Dalian Liaoning China; 2. Department of Emergency Central Hospital of Dalian Changxing Island Economic and Technological Development Zone Dalian Liaoning China; 3. Day Surgery Center The First Affiliated Hospital of Dalian Medical University Dalian Liaoning China
92
days
Neferine‐Targeted Inhibition of TrxR1 Triggers Apoptosis Through Disrupting Redox Homeostasis in Pancreatic Cancer Cells
AuthorsXiaoqing Yuan; Si Jiang; Guanqing Zhang; Yue Wang; Qiqiang Xie; Desheng Li; Tao Lu; Huan Liu; Xin Li; Jiayu Zhang; Maolei Xu; Ling Zhou
Affiliations1. School of Pharmacy, the Key Laboratory of Prescription Effect and Clinical Evaluation of State Administration of Traditional Chinese Medicine of China Shandong Medical and Pharmaceutical University Yantai P.R. China; 2. School of Traditional Chinese Medicine Shandong Medical and Pharmaceutical University Yantai P.R. China; 3. State Key Laboratory of Natural and Biomimetic Drugs Peking University Beijing P.R. China
123
days
Sodium Overload–Related Molecular Subtypes and a Four‐Gene Prognostic Signature Predict Survival, Immune Landscape, and Therapeutic Response in Acute Myeloid Leukemia
AuthorsYuan Wang; Yi Yang
Affiliations1. Department of Cardiothoracic Surgery Chongqing Qianjiang Central Hospital Chongqing China; 2. Department of Hematology Chongqing University Three Gorges Hospital Chongqing China
134
days
Cancer‐Associated Fibroblast‐Derived FGF7 Promotes Immune Escape in Oral Squamous Cell Carcinoma via JAK/STAT3‐Mediated PD‐L1 Expression
AuthorsQinghua Liu; Dongbin Chen; Juncai Lin; Qisong Wang; Fan Zhang
Affiliations1. Department of Stomatology Longyan First Affiliated Hospital of Fujian Medical University Longyan Fujian China
165
days
Breast Cancer‐Derived AZU1 Educates Neutrophils to Promote Tumor Progression and Metastasis Through PAD4‐Dependent Extracellular Trap Formation
AuthorsZhen Huang; Zhe Wu; Guiyue Zhu; Fangyu Qiu; Lihui Li; Yujie Xie; Chunyu Wei; Yinhua Pan; Quanqing Zou; Yuntian Tang
Affiliations1. Department of Breast Surgery The People's Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences Nanning Guangxi China; 2. The First Clinical Medical College Jinan University, Guangzhou Guangdong China; 3. Department of Gynaecology The People's Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences Nanning Guangxi China; 4. Department of Hepatobiliary Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences Nanning Guangxi China
68
days
Myeloid Focal Adhesion Kinase Promotes Macrophage Accumulation but Does Not Alter Tumor Progression in Hepatocellular Carcinoma
AuthorsEugene Ham; Kyle Boedeker; Claudia Rose Keating; Ruisong Ye; Frankie Montalbano; Sophia Mankaruse; Xianzhong Ding; Jonathan P. Rennhack; Wei Qiu
Affiliations1. Department of Surgery Loyola University Chicago Stritch School of Medicine Maywood Illinois USA; 2. Department of Cancer Biology Loyola University Chicago Stritch School of Medicine Maywood Illinois USA; 3. Department of Pathology and Laboratory Medicine Loyola University Chicago Stritch School of Medicine Maywood Illinois USA
130
days
Clinical and Molecular Features of BAP1‐Mutated Meningiomas: Case Series
AuthorsIvan Pradilla; Rasha Alfattal; Susan L. McGovern; Shaan M. Raza; Franco DeMonte; Leomar Y. Ballester; Chirag B. Patel; Carlos Kamiya‐Matsuoka
Affiliations1. Department of Neuro‐Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA; 2. Instituto Méderi del Cerebro, Cabeza y Cuello, Hospital Universitario Mayor, Méderi Universidad del Rosario Bogotá Colombia; 3. Molecular Genetic Pathology, Department of Pathology The University of Texas MD Anderson Cancer Center Houston Texas USA; 4. Neuropathology, Department of Pathology Houston Methodist Hospital Houston Texas USA; 5. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center University of Texas Houston Texas USA; 6. Department of Neurosurgery, The University of Texas MD Anderson Cancer Center University of Texas Houston Texas USA
175
days
Effects of Isorhapontigenin on Cell Viability, Colony‐Forming Efficiency, and Ferroptosis via Methyltransferase‐Like 14‐Mediated m 6 A Modification of Solute Carrier Family 7 Member 11 in Human Epidermal Growth Factor Receptor 2‐Enriched and Basal‐Like Breast Cancer
AuthorsZhong Li; Zhongji Zhang; Xi Lin
Affiliations1. Department of Thyroid and Breast Surgery Nanyang First People's Hospital Nanyang China; 2. Department of Thyroid, Breast, and Hernia Surgery Tiantai People's Hospital of Zhejiang Province Taizhou China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days